31.5K
Downloads
77
Episodes
The British Thoracic Oncology Group (BTOG) is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK.
BTOG's mission is to support and educate thoracic oncology healthcare professionals, creating a professional community to exchange ideas, information and innovation and to foster the development of research. The overall aim is to represent the needs of people with thoracic malignancies in the UK and ensure they have equitable access to optimal care.
Find out more here - https://www.btog.org/
Episodes
Jan 18, 2021
Jan 18, 2021
1 hr 6 min
Aims: to educate delegates on benefits of next generation sequencing (NGS) genotyping to identify
rare variants for NHS-reimbursed therapies, compassionate use programmes and trials enrolment.
All data will pertain to advanced NSCLC.
Chair: Professor Sanjay Popat
17:30 Introduction Sanjay Popat
17:31 BRAF, KRAS, & insertion mutations you need to know about Raffaele Califano
17:46 Splices and fusions you need to know about Alastair Greystoke
18:01 How will we find suitable patients? Rachel Butler
18:16 Q&A
18:30 Close
Dec 8, 2020
Dec 8, 2020
1 hr 4 min
BTOG Masterclass on Stage III NSCLC
Approved by the Federation of the Royal Colleges of Physicians of the United Kingdom
Nov 12, 2020
Oct 15, 2020
Oct 15, 2020
1 hr 5 min
Chair: Professor Sanjay Popat
Panel: Professor David Baldwin (Respiratory Medicine); Mr John Edwards (Surgery); Professor Samreen Ahmed (Medical Oncology); Professor Matthew Hatton (Clinical Oncology); Josie Roberts (Nursing); Dr Rhiannon Walters-Davies (Pharmacy)
Each panellist briefly summarises how practice has changed in their specialty and focus on moving forward with endemic COVID
Panel discussion & questions from webinar attendees.
Oct 15, 2020
Oct 15, 2020
1 hr 3 min
Chair: Dr Tom Newsom-Davis – BTOG Steering Committee Vice-Chair
Faculty:
Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospital Birmingham NHST
Dr David Gilligan, Consultant Oncologist and Associate Lecturer, University of Cambridge – Cambridge University Hospitals NHST
Professor James Spicer, Professor of Experimental Cancer Medicine and Consultant in Medical Oncology, King’s College London – Guy’s and St Thomas’ NHSFT
BTOG Steering Committee members will present an update on relevant data/research presented at ESMO 2020 on the topics below.
- Stage III NSCLC
- Small Cell Lung Cancer
- TKIs and Other Targeted Therapies
With Q&A after each presenter and at the end of whole session.
Oct 15, 2020
Oct 15, 2020
1 hr 3 min
Exploring studies and advances in thoracic oncology showcased at the IASLC WCLC 2020 Virtual Presidential Symposium on 8th August and the potential implications on UK practice.
View on demand at btogwebinars.org
Programme
Chair: Professor Sanjay Popat
The faculty will disseminate the trial data presented, discuss in UK context, and take questions.
ORIENT-11
Alastair Greystoke
Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC
(Speaker: Zhang Li, China)
eXalt3
Fiona Blackhall
Abstract 2: Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3
(Speaker: Leora Horn, USA)
CheckMate-743
Riyaz Shah
Abstract 3: First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
(Speaker: Paul Baas, Netherlands)
Faculty
Professor Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research and Chair of the BTOG Steering Committee
Dr Alastair Greystoke is Clinical Senior Lecturer and Honorary Consultant at the Newcastle University and the Northern Centre for Cancer Care
Professor Fiona Blackhall is Professor of Thoracic Oncology and Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust
Dr Riyaz Shah is a Consultant Medical Oncologist at Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Oct 15, 2020
Oct 15, 2020
1 hr 40 sec
In collaboration with Roy Castle Lung Cancer Foundation (RCLCF)
Approved for 1 CPD credit by the Federation of the Royal Colleges of Physicians of the United Kingdom (Ref: 131661) until July 2nd 2020.
BTOG and RCLCF usually hold an annual in-person meeting to highlight the latest thoracic oncology treatment and research showcased at the annual ASCO meeting. For ASCO 2020, which is going ahead virtually, we are going to present a one hour webinar
Join BTOG Steering Committee members for an update on relevant data/research presented at ASCO 2020 on:
- advanced stage NSCLC: immunotherapy
- advanced stage NSCLC: targeted therapies
- locally advanced NSCLC
- SCLC and
- mesothelioma